Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thiocitrulline is a compound that has been investigated for its biological activities. A specific derivative, S-methyl-L-thiocitrulline (SMTC), functions as a selective inhibitor of neuronal nitric oxide synthase (nNOS), an enzyme crucial for nitric oxide production. SMTC has been widely utilized in research to elucidate the physiological roles of nNOS in various systems, including neurovascular regulation, cerebral blood flow, cardiac contractility, and blood pressure control, and its involvement in conditions such as hypertension and mental stress-induced vasodilation. Additionally, thiocitrulline itself has been studied for its binding capabilities to the SARS-CoV-2 main protease, suggesting a potential role as a supplement in the treatment of SARS-CoV-2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Thiocitrulline.